REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 1st, 2019 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of September 19, 2019 by and among Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the “Lenders” named in that certain Loan and Security Agreement by and among the Company and the Lenders, dated September 3, 2019 (the “Loan Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Loan Agreement unless otherwise defined herein.
COMMON STOCK PURCHASE WARRANT SPRING BANK PHARMACEUTICALS, INC.Common Stock Purchase Warrant • November 1st, 2019 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Pontifax Medison Finance ( ) L.P. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time prior to the close of business on the sixth-year anniversary of the Closing Date (as defined in the Loan Agreement)2 (such 6th anniversary, the “Termination Date”) but not thereafter, to subscribe for and purchase from Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ___ shares of Common Stock (the “Warrant Shares”). The purchase price for each Warrant Share shall be equal to the Exercise Price as defined in Section 2(d).
